A Novel Antiviral Treatment of Hepatitis C Virus Reactivation in a Breast Cancer Patient Undergoing Chemotherapy

被引：1
|
作者：
Wu Yu-Tuan
Xu Zhou
Chen Hao-Ran
Arshad Bilal
Li Hong-Yuan
Wu Kai-Nan
Kong Ling-Quan
机构：
[1] China
[2] Chongqing 400016
[3] Department of Endocrine and Breast Surgery
[4] The First Affiliated Hospital of Chongqing Medical University
来源：
中华医学杂志英文版 | 2017年 / 130卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R512.63 []; R737.9 [乳腺肿瘤];
学科分类号：
100214 ; 100401 ;
摘要：
To the Editor: Viral hepatitis is a major public health concern worldwide, and hepatitis B virus (HBV), with which two billion people infected globally, has been commonly reported to undergo reactivat
引用
收藏
页码：2015 / 2016
页数：2
相关论文
共 50 条
  • [31] Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
    Yeo, W
    Ho, WM
    Hui, P
    Chan, PKS
    Lam, KC
    Lee, JJ
    Johnson, PJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (03) : 209 - 215
  • [32] Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
    Yeo, W
    Chan, PKS
    Hui, P
    Ho, WM
    Lam, KC
    Kwan, WH
    Zhong, S
    Johnson, PJ
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) : 553 - 561
  • [33] Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
    Winnie Yeo
    Wing M. Ho
    Pun Hui
    Paul K. S. Chan
    Kwok C. Lam
    Jam J. Lee
    Philip J. Johnson
    Breast Cancer Research and Treatment, 2004, 88 : 209 - 215
  • [34] Angiogenic Cytokines in Patients Undergoing Antiviral Treatment for Chronic Hepatitis C Virus Infection
    Vespasiani-Gentilucci, Umberto
    Galati, Giovanni
    Mazzarelli, Chiara
    D'Avola, Delia
    Spataro, Sandro
    Gallo, Paolo
    Rigon, Amelia
    Pellicelli, Adriano
    Dicuonzo, Giordano
    Afeltra, Antonella
    Picardi, Antonio
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (02): : 207 - 210
  • [35] Lamivudine for the prevention of hepatitis B virus reactivation in hbsag seropositive cancer patients undergoing cytotoxic chemotherapy
    Yeo, W.
    Ho, W. M.
    Hui, P.
    Lam, C. K.
    Zee, B.
    Kwan, W. H.
    Chan, P. K. S.
    Lee, J. J.
    Johnson, P. J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 142 - 142
  • [36] The treatment of severe hepatitis B virus reactivation after chemotherapy
    Xing Li
    Yan-Fang Xing
    Qu Lin
    Min Dong
    Xiang-Bo Wan
    Xiang-Yuan Wu
    Nature Reviews Clinical Oncology, 2012, 9 : 350 - 350
  • [37] The treatment of severe hepatitis B virus reactivation after chemotherapy
    Li, Xing
    Xing, Yan-Fang
    Lin, Qu
    Dong, Min
    Wan, Xiang-Bo
    Wu, Xiang-Yuan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 350 - 350
  • [38] Summary: Antiviral treatment of hepatitis c virus
    Dusheiko, GM
    ANTIVIRAL RESEARCH, 1996, 29 (01) : 77 - 82
  • [39] The Safety of Chemotherapy for Breast Cancer Patients with Hepatitis C Virus Infection
    Miura, Yuji
    Theriault, Richard L.
    Naito, Yoichi
    Suyama, Koichi
    Shimomura, Akihiko
    Iwatani, Tsuguo
    Miura, Daishu
    Kawabata, Hidetaka
    Kumada, Hiromitsu
    Takano, Toshimi
    JOURNAL OF CANCER, 2013, 4 (06): : 519 - 523
  • [40] The Safety of Chemotherapy for Breast Cancer Patients With Hepatitis C Virus Infection
    Miura, Y.
    Naito, Y.
    Shimomura, A.
    Iwatani, T.
    Miura, D.
    Kawabata, H.
    Takano, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S240 - S240
12345